The first Drug Enforcement Administration (DEA) hearing on the Biden administration’s cannabis rescheduling proposal took place on December 2, with proponents and opponents appearing for a largely procedural meeting to prepare for more substantive hearings in 2025. The center of the case concerns the administration’s push to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA).  Read the article here.